Most drugs operate via the membranes that surround the body’s cells. A study by researchers at Karolinska Institutet in Sweden has now mapped the structure and mechanism of MGST2, a membrane enzyme that, amongst other things, plays a part in chronic inflammation and cancer. The study, which is published in the journal Nature Communications, can make a significant contribution to the development of future drugs.
Click here for original story, 3D structure and mechanism of membrane protein MGST2 identified, paving way for drug developments
Source: Phys.org